Semaglutide, a GLP-1 weight loss drug, slowed biological aging across multiple epigenetic clocks in a randomized, double-blind, placebo-controlled clinical tria... (opens in new tab)

A study by UC San Diego researchers and their colleagues has found that semaglutide slows down the accumulation of biological aging markers in the DNA of adults with HIV, pointing to the potential of GLP‑1 receptor agonists to help prevent age‑related diseases.